Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Novel Anacor Pharmaceuticals compound reduces inflammation in vivo

May 22, 2012

ASLAN obtains global rights to Almirall's DHOdehase inhibitor

May 21, 2012

Novel IL-17 production inhibitors synthesized by Japanese group

May 16, 2012

Galapagos kicks off new study of novel JAK1 inhibitor

May 14, 2012

Novel OSM-directed antibodies created at Janssen Biotech

May 14, 2012

Seikagaku and Kaken report on agreement for lumbar disc herniation treatment candidate

May 11, 2012

FDA committee recommends approval of Pfizer product for RA

May 10, 2012

Double-blind trial assesses secukinumab for psoriatic arthritis

May 9, 2012

Investigation at Roche yields novel TWEAK-specific antibodies

May 8, 2012

Encouraging phase I data reported on candidate arthritis immunotherapy

May 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...